Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions-Reference-Cited by-同舟云学术

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions

Published:2012-04 Issue:19 Volume:30 Page:2963-2972
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Oliver Liliana,Fernández Audry,Raymond Judith,López-Requena Alejandro,Fernández Luis E.,Mesa Circe

Funder

Center of Molecular Immunology (Havana, Cuba)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children;Scott;J Immunol,2003

2. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice;Crawford;J Natl Compr Canc Netw,2008

3. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT;Ljungman;Bone Marrow Transplant,2005

4. Does the immune system see tumors as foreign or self?;Pardoll;Annu Rev Immunol,2003

5. A sense of tumour for the immune system;Todryk;Immunology,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer;Cell Communication and Signaling;2023-04-13

2. Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies;Frontiers in Oncology;2022-11-02

3. The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study;Archives of Cancer Science and Therapy;2022-09-20

4. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator;Journal for ImmunoTherapy of Cancer;2022-09

5. Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction;Seminars in Oncology;2018-01